LSE:APH (Alliance Pharma plc)

About APH

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of pharmaceutical products. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from Kelo-cote brand. Geographically, it derives a majority of revenue from Europe, Middle East and Africa (EMEA).
  • Alliance Pharma plc (LSE: APH) Latest News

    Investing Articles

    2 UK health stocks I’d buy after this news

    The shares of many UK health stocks have been flying in the market crash. G A Chester reckons these two…

    Read more »

    Investing Articles

    AIM stocks to watch: I think the PAF and APH share prices look promising

    With a high gold price, the PAF share price is thriving, and APH's strong product lines could stand it in…

    Read more »

    Investing Articles

    Why I’d sell this FTSE 100 stock and buy this small-cap share

    G A Chester sees the valuation of this flying FTSE 100 stock as far too dizzy, but finds good value…

    Read more »

    Investing Articles

    Stock market crash: I’d buy this small-cap healthcare share

    I reckon this company is in good shape for surviving and trading through the current crisis and will likely return…

    Read more »

    Investing Articles

    £5k to invest? 2 inflation-beating dividend stocks I’d buy to protect my shares portfolio

    Looking to load up following the recent share market sell-off? These dividend heroes could be more resilient than most as…

    Read more »

    Investing Articles

    3 FTSE stocks I’d stockpile during the coronavirus pandemic

    G A Chester highlights two resilient FTSE 100 stocks and a solid, smaller-cap company that could deliver high long-term growth…

    Read more »

    Investing Articles

    Worried about diving markets? I reckon this safe haven stock could protect your shares portfolio

    Royston Wild discusses another brilliant flight-to-safety stock that could thrive next month.

    Read more »

    Investing Articles

    Have £4k to invest in your ISA? 2 dividend growth stocks I’d buy and hold ‘til 2030

    Are you seeking to generate chunky income flows from your Stocks & Shares ISA? Of course you are. And these…

    Read more »

    Investing Articles

    Why I think this small-cap stock could trash the Marks & Spencer share price

    A defensive business with strong profit and dividend growth, this small-cap stock could knock spots off Marks & Spencer, argues…

    Read more »

    Investing Articles

    Have £5k to spend? 2 top growth AND dividend stocks I’d buy for my ISA today

    Got some money in your back pocket that you're itching to invest? Take a close look at these growth and…

    Read more »

    Investing Articles

    Why I’d still buy the GSK share price after its 10% rise

    G A Chester still sees good value in GlaxoSmithKline plc (LON:GSK) and in a smaller-cap sector peer.

    Read more »

    Investing Articles

    Is the AstraZeneca share price a FTSE 100 bargain?

    G A Chester discusses the investment case for FTSE 100 (INDEXFTSE:UKX) giant AstraZeneca plc (LON:AZN) and a small-cap pharma firm…

    Read more »